IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CRTD

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q1 2025Q4 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.340.250.220.740.020.070.010.100.170.710.441.563.233.791.512.122.80
Short-term Investments4.550.100.25--0.07--------0.000.000.05--------0.10
Accounts Receivable0.030.010.01--0.00--0.040.070.240.240.220.380.390.340.390.280.15
Inventory------------0.110.170.260.400.880.430.440.110.09----
Total Current Assets8.4410.910.74--0.09--0.360.710.951.481.682.604.334.482.553.303.52
Property, Plant & Equipment0.180.020.01--0.02--0.140.180.200.210.250.250.140.100.090.060.06
Goodwill0.000.000.00--0.01--0.050.050.050.051.371.381.381.371.981.041.04
Intangible Assets0.020.030.03--0.10--0.180.190.200.232.542.532.522.432.491.490.93
Total Non-current Assets*1.381.211.21--2.18--2.533.223.533.347.047.535.014.705.703.312.92
Total Assets9.8212.1318.14--2.26--2.893.934.484.828.7210.139.349.178.256.616.44
Accounts Payable3.975.065.29--8.45--13.4412.6011.117.576.714.904.833.732.732.951.85
Short-term Debt------------1.591.471.601.681.791.901.191.341.091.091.48
Total Current Liabilities7.328.347.56--11.29--21.6920.7317.7815.2115.179.506.195.425.394.824.29
Long-term Debt------------0.04--------------0.642.10--
Total Non-current Liabilities0.030.050.01--1.27--1.922.242.052.122.162.130.040.060.742.240.18
Total Liabilities7.358.399.07--12.56--23.6122.9719.8317.3217.3411.636.235.496.137.064.47
Retained Earnings(280.22)(277.35)(262.93)--(252.80)--(190.48)(179.06)(168.39)(146.14)(133.76)(124.31)(115.98)(109.63)(97.34)(87.54)(78.57)
Total Stockholder Equity(0.39)0.693.67--(13.99)--(21.61)(19.92)(15.70)(11.75)(9.29)(2.40)1.851.810.82(0.51)1.97
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q2 2025Q1 2025Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Total Revenue0.170.200.200.290.440.700.990.801.021.631.351.411.180.970.74
Cost of Revenue*0.030.000.050.040.360.441.011.341.401.791.571.141.42--0.00
Gross Profit0.140.200.150.250.080.26(0.03)(0.54)(0.38)(0.17)(0.22)0.27(0.24)--0.74
Research & Development--0.04----0.540.050.130.270.230.220.230.280.320.060.33
Selling, General & Admin0.640.720.020.730.661.281.58(1.68)3.844.183.39(0.85)2.393.166.36
Total Operating Expenses2.4312.542.742.252.002.9713.697.515.607.826.799.656.679.356.69
Operating Income(2.29)(12.34)(2.59)(2.00)(1.92)(2.71)(13.71)(8.05)(5.98)(7.99)(7.01)(12.13)(6.91)(8.38)(5.95)
Interest Expense--0.02--0.070.470.090.070.110.670.020.010.050.060.060.20
Pretax Income(2.48)(13.44)(1.38)(1.74)(2.92)(4.47)(15.96)(10.56)(9.53)(8.70)(6.88)------(6.64)
Tax Provision0.00----------------------------
Net Income(2.49)(14.42)(1.34)(2.00)(2.92)(4.45)(15.91)(7.85)(9.23)(8.34)(6.88)(12.44)(9.74)(8.56)(6.64)
Basic EPS--------(0.09)(0.12)(0.35)(0.44)(0.45)(0.41)(0.36)--------
Diluted EPS--------(0.09)(0.12)(0.35)(0.37)(0.45)(0.41)----------
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q1 2025Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(2.36)(1.31)(0.71)(0.19)(0.33)(2.86)(2.95)(3.24)(5.58)(5.04)(4.90)(4.62)(5.70)(5.30)
Capital Expenditures0.180.01---------0.000.040.130.040.030.040.010.01
Free Cash Flow*(2.54)(1.32)--------(2.95)(3.28)(5.71)(5.08)(4.93)(4.66)(5.71)(5.31)
Investing Cash Flow2.380.98--0.000.000.250.87(0.13)(0.32)(0.05)0.16(0.58)(0.53)(0.21)
Financing Cash Flow0.100.361.430.100.262.072.342.284.254.537.064.595.560.41
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2023Q2 2023
Dividends Per Share0.200.08
← Scroll for more columns →